Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Dreyer

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
British Journal of Cancer|May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinomaKatharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1989
Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic proteaseT D Meek, B D Dayton, B W Metcalf, et al.
The British Journal of Surgery|May 7, 2026
Clinical and molecular landscape of surgically resected early onset pancreatic cancerStephan B Dreyer, Adam Bryce, Fieke Froeling, et al.
Nature|January 14, 1990
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analoguesT D Meek, D M Lambert, G B Dreyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitorsG B Dreyer, B W Metcalf, T A Tomaszek, et al.
Biochemical and Biophysical Research Communications|March 15, 1989
Peptide substrates and inhibitors of the HIV-1 proteaseM L Moore, W M Bryan, S A Fakhoury, et al.
Antimicrobial Agents and Chemotherapy|May 11, 1992
Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cellsD M Lambert, S R Petteway, C E McDanal, et al.
Ophthalmology|August 26, 1998
Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplastyR S Ayyala, L Pieroth, A F Vinals, et al.
Chinese Clinical Oncology|May 10, 2019
Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profilingStephan B Dreyer, Nigel B Jamieson, Lisa Evers, et al.
Annals of Surgery|February 6, 2023
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic CancerStephan B Dreyer, Sarah Rae, Kirsty Bisset, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
British Journal of Cancer|May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinomaKatharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1989
Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic proteaseT D Meek, B D Dayton, B W Metcalf, et al.
The British Journal of Surgery|May 7, 2026
Clinical and molecular landscape of surgically resected early onset pancreatic cancerStephan B Dreyer, Adam Bryce, Fieke Froeling, et al.
Nature|January 14, 1990
Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analoguesT D Meek, D M Lambert, G B Dreyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitorsG B Dreyer, B W Metcalf, T A Tomaszek, et al.
Biochemical and Biophysical Research Communications|March 15, 1989
Peptide substrates and inhibitors of the HIV-1 proteaseM L Moore, W M Bryan, S A Fakhoury, et al.
Antimicrobial Agents and Chemotherapy|May 11, 1992
Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cellsD M Lambert, S R Petteway, C E McDanal, et al.
Ophthalmology|August 26, 1998
Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplastyR S Ayyala, L Pieroth, A F Vinals, et al.
Chinese Clinical Oncology|May 10, 2019
Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profilingStephan B Dreyer, Nigel B Jamieson, Lisa Evers, et al.
Annals of Surgery|February 6, 2023
The Impact of Molecular Subtyping on Pathological Staging of Pancreatic CancerStephan B Dreyer, Sarah Rae, Kirsty Bisset, et al.
Pageof 14